{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-25-125040","form_type":"8-K","ticker":"BMRN","cik":"0001048477","company_name":"BIOMARIN PHARMACEUTICAL INC","filed_at":"2025-05-22T23:59:59+00:00","discovered_at":"2026-05-14T18:02:47.309613+00:00","generated_at":"2026-05-20T17:18:20.242760+00:00","sec_items":["5.02","5.07"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"BioMarin shareholders approve 8M share increase in equity plan, re-elect all directors","bullets":["Shareholders approved 8M additional shares under the 2017 Equity Incentive Plan (157.3M for, 7.7M against).","All ten director nominees, including Elizabeth Anderson and Alexander Hardy, re-elected.","KPMG ratified as independent auditor for FY2025 with 168.6M votes in favor.","Advisory vote on executive compensation passed with over 93% support of votes cast."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-25-125040","json":"https://secwatch.observer/filing/0001193125-25-125040.json","markdown":"https://secwatch.observer/filing/0001193125-25-125040.md","text":"https://secwatch.observer/filing/0001193125-25-125040.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1048477/000119312525125040/0001193125-25-125040-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1048477/000119312525125040/d947689d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-20T17:18:20.242760+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}